DGAP-News: BLACKHAWK GROWTH'S MINDBIO THERAPEUTICS SUCESSFULLY PROGRESSED TO THE SECOND HALF OF THEIR PHASE 1 MICRODOSING CLINICAL TRIAL

The progress in clinical trials makes MindBio a step closer towards commercialization and bringing new therapies to market.